[go: up one dir, main page]

FR16C0040I2 - Gene chimerique forme par les sequences d'adn codant pour les determinants antigeniques de quatre proteines de l. infantum - Google Patents

Gene chimerique forme par les sequences d'adn codant pour les determinants antigeniques de quatre proteines de l. infantum

Info

Publication number
FR16C0040I2
FR16C0040I2 FR16C0040C FR16C0040C FR16C0040I2 FR 16C0040 I2 FR16C0040 I2 FR 16C0040I2 FR 16C0040 C FR16C0040 C FR 16C0040C FR 16C0040 C FR16C0040 C FR 16C0040C FR 16C0040 I2 FR16C0040 I2 FR 16C0040I2
Authority
FR
France
Prior art keywords
dna sequences
chimeric gene
antigenic determinants
sequences coding
gene formed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR16C0040C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Leti SA
Original Assignee
Laboratorios Leti SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA2256124A external-priority patent/CA2256124C/fr
Priority claimed from EP99967987A external-priority patent/EP1141305B1/fr
Publication of FR16C0040I1 publication Critical patent/FR16C0040I1/fr
Application filed by Laboratorios Leti SA filed Critical Laboratorios Leti SA
Application granted granted Critical
Publication of FR16C0040I2 publication Critical patent/FR16C0040I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR16C0040C 1998-12-23 2016-10-19 Gene chimerique forme par les sequences d'adn codant pour les determinants antigeniques de quatre proteines de l. infantum Active FR16C0040I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11382598P 1998-12-23 1998-12-23
CA2256124A CA2256124C (fr) 1998-12-23 1998-12-23 Gene chimere forme de sequences d'adn codant pour les sites antigeniques de quatre proteines de l. infantum, proteine codee par le gene en question et composition pharmaceutique utile pour prevenir et/ou traiter la leishmaniose chez les animaux ou les humains
EP99967987A EP1141305B1 (fr) 1998-12-23 1999-12-23 Gene chimerique forme par les sequences d'adn codant pour les determinants antigeniques de quatre proteines de l. infantum

Publications (2)

Publication Number Publication Date
FR16C0040I1 FR16C0040I1 (fr) 2016-09-12
FR16C0040I2 true FR16C0040I2 (fr) 2018-07-27

Family

ID=35612619

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C0040C Active FR16C0040I2 (fr) 1998-12-23 2016-10-19 Gene chimerique forme par les sequences d'adn codant pour les determinants antigeniques de quatre proteines de l. infantum

Country Status (3)

Country Link
EP (1) EP1624063B1 (fr)
FR (1) FR16C0040I2 (fr)
SI (1) SI1141305T1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120061082A (ko) * 2009-07-13 2012-06-12 라보라토리오스 레티, 에스.엘. 리보솜 단백질 추출물(ｒｐｅ)을 이용한 리슈만편모충증과 같은 기생충 질병의 진단 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0703295A1 (fr) * 1994-09-26 1996-03-27 Institut Pasteur Vaccin comprenant un BCG recombinant exprimant une protéine de fusion de GP63
US5912166A (en) * 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
ES2133236B1 (es) * 1997-06-27 2000-04-16 Leti Lab Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida.

Also Published As

Publication number Publication date
FR16C0040I1 (fr) 2016-09-12
EP1624063B1 (fr) 2009-04-22
EP1624063A2 (fr) 2006-02-08
EP1624063A3 (fr) 2006-07-05
SI1141305T1 (sl) 2006-10-31

Similar Documents

Publication Publication Date Title
MA22905A1 (fr) Nouvelles sequences d'adn .
EP1018549A4 (fr) Technique d'isolation d'adn
FR07C0023I2 (fr) Adn codant le virus du papillome de type 18 humain
ATE315088T1 (de) Tumorassoziierte antigenderivate der mage-familie,nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
EP0870832A4 (fr) Nouvelle adn polymerase
ES2181799T3 (es) Conjugados de acidos peptido nucleicos.
DE60042556D1 (de) Für polyepitop-polypeptide kodierende nukleinsäuren
CY2016033I2 (el) Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
EP1578901A4 (fr) Fragments d'adn lineaires destines a l'expression genetique
FR2753204B1 (fr) Procede de preparation d'adn plasmidique
HU0003893D0 (en) Novel nucleotide sequences coding for the eno gene
FR2645157B1 (fr) Inhibition selective de l'adn polymerase
ZA961082B (en) DNA sequence.
FR16C0040I2 (fr) Gene chimerique forme par les sequences d'adn codant pour les determinants antigeniques de quatre proteines de l. infantum
IS4629A (is) Samskeyttar veirukjarnsýrur
NZ294019A (en) Proteins associated with the hippocampus; dna sequences coding therefor, antibodies to the proteins
EP1109824A4 (fr) Proteines bag et molecules d'acide nucleique les codant
FR2709132B1 (fr) Fragment d'ADN portant le gène codant pour l'enzyme de fragmentation du N-acétylhéparosane et les séquences adjacentes permettant son expression, enzyme recombinée et son utilisation.
EP1040183A4 (fr) Acide nucleique codant pour l'ubr1 de mammifere
NO20021614D0 (no) DNA kodende for PROST 07-polypeptid
EP1181316A4 (fr) RECEPTEURS SNORF 36a ET SNORF 36b CODANT POUR L'ADN
EP1007540A4 (fr) Molecules d'adn codant pour des proteines receptrices nucleaires
DE59805686D1 (de) Verfahren zur Herstellung von Beta-Alkoxy-nitrilen
EP1019086A4 (fr) Composants modifies de synthesome d'adn
EP1262487A4 (fr) Promoteur de squalene epoxydase codant l'adn